BSYI — BioSyntech Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for BioSyntech, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2005 March 31st | 2006 March 31st | 2007 March 31st | R2008 March 31st | 2009 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.901 | 10.9 | 11.9 | 2.84 | 3.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.225 | 0.301 | 0.847 | 0.889 | 1.34 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.21 | 11.4 | 13 | 3.92 | 5.36 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.72 | 2.58 | 2.46 | 2.19 | 1.84 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 4.76 | 14.7 | 16.4 | 6.12 | 7.2 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.06 | 4.25 | 1.94 | 1.92 | 11.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 6.52 | 6.14 | 5.24 | 4.46 | 13.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -1.76 | 8.59 | 11.2 | 1.66 | -6.66 |
| Total Liabilities & Shareholders' Equity | 4.76 | 14.7 | 16.4 | 6.12 | 7.2 |
| Total Common Shares Outstanding |